This contract involves the supply of the medication Burosumab as part of a treatment program for patients with X-Linked Hypophosphatemia (XLH), classified under ICD-10 code E.83.3. The contracting authority does not allow partial bids, meaning the contract cannot be divided into smaller parts. Addit
Contract awarded. Originally published 1 years ago.
This contract involves the supply of laboratory reagents, probes, microarrays, laboratory fluids, and DNA purification and isolation kits. Suppliers can submit partial offers divided into 7 parts, and they are allowed to bid on any number of parts. Detailed descriptions and execution methods are pro
This contract involves the supply of various medical products, including medications, chemotherapy drugs, and medical devices. The buyer, the Institute of Mother and Child in Poland, is seeking suppliers who can provide these essential health products. The deadline for submitting proposals is Octobe
The contract involves the procurement of newborn screening kits for the detection of lysosomal storage diseases, specifically: Pompe disease (measuring alpha-glucosidase activity), Fabry disease (measuring alpha-galactosidase A activity), Gaucher disease (measuring glucocerebrosidase activity), and
This contract involves the supply of laboratory reagents for various genetic testing purposes, including screening for cystic fibrosis, organic acid profile analysis using GC/MS, genetic and molecular testing, QF-PCR, and NGS diagnostics. Detailed specifications and execution methods are provided in
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
